Researcher Profile

Researcher Profile

Rogerio Neves, MD, PhD

Rogerio Neves, MD, PhD

Professor, Department of Surgery
Division of Plastic Surgery
Professor, Department of Dermatology
Professor, Department of Pharmacology
Professor, Department of Medicine
Disease Teams:
Breast Cancer
Melanoma and Skin Cancer
Sarcoma Cancer
rin2@psu.edu

Research Interests

  • Melanoma
  • Skin
  • Therapeutics
  • Neoplasms
  • Mammaplasty
  • Neck
  • Head
  • Sentinel Lymph Node Biopsy
  • Tissue Expansion
  • Wounds and Injuries
  • Survival
  • Lymph Nodes

Clinical Trials

MATCH Treatment Subprotocol C2: Crizotinib in Patients with Tumors with MET Exon 14 Deletion
MATCH Treatment Subprotocol E: AZD9291 in Patients with Tumors Having EGFR T790M Mutations (Except Non-Small Cell Lung Cancer) or Rare Activating Mutations of EGFR
MATCH Treatment Subprotocol F: Crizotinib in Patients with Tumors (Other Than Adenocarcinoma of Lung or ALCL) with ALK Rearrangements
MATCH Treatment Subprotocol G: Phase II Study of Crizotinib in Patients with ROS1 Translocations (Other Than Patients with Non-Small Cell Lung Cancer)
MATCH Treatment Subprotocol T: GDC-0449 (vismodegib) in Patients with Tumors (except basal cell skin carcinoma) with Smoothened (SMO) or Patched 1 (PTCH1) Mutations
MATCH Treatment Subprotocol V: Phase II Study of Sunitinib in Patients with Tumors with c-Kit Mutations (Excluding GIST, Renal Cell Carcinoma or Pancreatic Neuroendocrine Tumor).
A Phase II Study of REGN2810, a Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy or were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
Development and Validation of a Gene Expression Assay to Predict the Risk of Recurrent Disease in Cutaneous Squamous Cell Carcinoma
SPY-X: A Study to Assess the Feasibility of Using Real-time Fluorescence Lymphangiography Alone for Sentinel Node Localization in Patients with Melanoma or Breast Cancer
Performance of the DecisionDx-Melanoma Gene Expression Profile Test for Prognosis of Recurrence Risk
DecisionDx-Melanoma Gene Expression Profile Test Result to Predict Risk of Sentinel Lymph Node (SLN) Metastasis
The Collection of Blood, Tissue and Phenotypic Data in Patients Diagnosed with Skin Cancers and Subsequent Metastases for Inclusion in a Repository and Use in Outcome Studies
Atypical Spotzoid Melanocytic Tumors: An Institutional Review of Outcomes for an Effective Treatment
Application for Discarded Tissue From Surgery For Research Use
Definition of Somatic Variants Corresponding to Immune Targets in Patients with Metastatic Melanoma

Recent Publications

2018

Pameijer, CR, Leung, A, Neves, R & Zhu, J 2018, 'Indocyanine green and fluorescence lymphangiography for sentinel node identification in patients with melanoma', American Journal of Surgery, vol. 216, no. 3, pp. 558-561. https://doi.org/10.1016/j.amjsurg.2018.01.009
Dinavahi, SS, Noory, MA, Gowda, R, Drabick, J, Berg, A, Neves, R & Robertson, G 2018, 'Moving synergistically acting drug combinations to the clinic by comparing sequential versus simultaneous drug administrations', Molecular pharmacology, vol. 93, no. 3, pp. 190-196. https://doi.org/10.1124/mol.117.110759
Gowda, R, Dinavahi, SS, Iyer, S, Banerjee, S, Neves, R, Pameijer, CR & Robertson, G 2018, 'Nanoliposomal delivery of cytosolic phospholipase A2 inhibitor arachidonyl trimethyl ketone for melanoma treatment', Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 14, no. 3, pp. 865-875. https://doi.org/10.1016/j.nano.2017.12.020

2017

Faries, B, Thompson, JF, Cochran, AJ, Andtbacka, RH, Mozzillo, N, Zager, JS, Jahkola, T, Bowles, TL, Testori, A, Beitsch, PD, Hoekstra, HJ, Moncrieff, M, Ingvar, C, Wouters, MWJM, Sabel, MS, Levine, EA, Agnese, D, Henderson, M, Dummer, R, Rossi, CR, Neves, R, Trocha, SD, Wright, F, Byrd, DR, Matter, M, Hsueh, E, MacKenzie-Ross, A, Johnson, DB, Terheyden, P, Berger, AC, Huston, TL, Wayne, JD, Smithers, BM, Neuman, HB, Schneebaum, S, Gershenwald, JE, Ariyan, CE, Desai, DC, Jacobs, L, McMasters, KM, Gesierich, A, Hersey, P, Bines, SD, Kane, JM, Barth, RJ, McKinnon, G, Farma, JM, Schultz, E, Vidal-Sicart, S, Hoefer, RA, Lewis, JM, Scheri, R, Kelley, MC, Nieweg, OE, Noyes, RD, Hoon, DSB, Wang, HJ, Elashoff, DA & Elashoff, RM 2017, 'Completion dissection or observation for sentinel-node metastasis in melanoma', New England Journal of Medicine, vol. 376, no. 23, pp. 2211-2222. https://doi.org/10.1056/NEJMoa1613210
Koller, KM, Mackley, H, Liu, J, Wagner Jr., H, Talamo, G, Schell, T, Pameijer, CR, Neves, R, Anderson, B, Kokolus, KM, Mallon, CA & Drabick, J 2017, 'Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone', Cancer Biology and Therapy, vol. 18, no. 1, pp. 36-42. https://doi.org/10.1080/15384047.2016.1264543

2016

Lacouture, ME, Dréno, B, Ascierto, PA, Dummer, R, Basset-Seguin, N, Fife, K, Ernst, S, Licitra, L, Neves, R, Peris, K, Puig, S, Sokolof, J, Sekulic, A, Hauschild, A & Kunstfeld, R 2016, 'Characterization and management of hedgehog pathway inhibitor-related adverse events in patients with advanced basal cell carcinoma', Oncologist, vol. 21, no. 10, pp. 1218-1229. https://doi.org/10.1634/theoncologist.2016-0186
Koller, KM, Wang, W, Schell, T, Cozza, EM, Kokolus, KM, Neves, R, Mackley, H, Pameijer, CR, Leung, A, Anderson, B, Mallon, CA, Robertson, G & Drabick, J 2016, 'Malignant melanoma—The cradle of anti-neoplastic immunotherapy', Critical Reviews in Oncology/Hematology, vol. 106, pp. 25-54. https://doi.org/10.1016/j.critrevonc.2016.04.010
Morrow, BT, Albright, WB, Neves, R, Wilkinson, M & Samson, T 2016, 'Orbital expansion for congenital anophthalmia may be achievable in infancy but not in childhood', Journal of Craniofacial Surgery, vol. 27, no. 7, pp. 1642-1646. https://doi.org/10.1097/SCS.0000000000002937

2015

Wyluda, EJ, Cheng, J, Schell, T, Haley, JS, Mallon, C, Neves, R, Robertson, G, Sivik, J, Mackley, H, Talamo, G & Drabick, J 2015, 'Durable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy' Cancer Biology and Therapy, vol. 16, no. 5, pp. 662-670. https://doi.org/10.1080/15384047.2015.1026507
Clawson, GA, Matters, GL, Xin, P, Imamura-Kawasawa, Y, Du, Z, Thiboutot, DM, Helm, KF, Neves, RI & Abraham, T 2015, 'Macrophage-tumor cell fusions from peripheral blood of melanoma patients', PloS one, vol. 10, no. 8, e0134320. https://doi.org/10.1371/journal.pone.0134320

Clinical Trials Search


Children (age < 18 years)
Adults (age >= 18 years)